Kailera Therapeutics, Inc. (KLRA)

SEC filing

Kailera Therapeutics, Inc.

KLRA · CIK 2096997

4 · Apr 20, 2026 · BCLS Fund IV Investments bought 1.56M shares at $16.00/share ($25.0M); converted 21.02M shares

BCLS Fund IV Investments bought 1.56M shares at $16.00/share ($25.0M); converted 21.02M shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

ck0002096997-ex99_1.htm

ck0002096997-ex99_1.htmSEC.gov

Graphics and non-inline formats (not embedded below).